We observed a significantly lower expression of CD46 and CD55 on the surface of lymphocytes, monocytes and granulocytes and higher surface expression of CD35 and CD59 on granulocytes (p < 0.0001) in CAD patients compared to healthy donors (Figure 1). The gene discussed is CD59; the disease is coronary artery disorder.